These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12182172)

  • 1. New medication recommended for Parkinson's disease.
    Levenson D
    Rep Med Guidel Outcomes Res; 2001 Jun; 12(13):7-9. PubMed ID: 12182172
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
    Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine for psychosis in Parkinson's disease.
    Pfeiffer RF; Kang J; Graber B; Hofman R; Wilson J
    Mov Disord; 1990; 5(3):239-42. PubMed ID: 2388641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson's: integrating the primary and secondary care guidelines.
    Macmahon D; Brooks D; Smith R
    Practitioner; 2000 Apr; 244(1609):370-8. PubMed ID: 10892059
    [No Abstract]   [Full Text] [Related]  

  • 6. Clozapine withdrawal symptoms in a Parkinson's disease patient.
    Zesiewicz TA; Borra S; Hauser RA
    Mov Disord; 2002 Nov; 17(6):1365-7. PubMed ID: 12465085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine agonists for Parkinson's disease.
    Sharma J; MacMahon D; Stewart D
    Lancet; 2003 Jan; 361(9351):84; author reply 84. PubMed ID: 12517504
    [No Abstract]   [Full Text] [Related]  

  • 9. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738
    [No Abstract]   [Full Text] [Related]  

  • 10. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
    Kondo T
    J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease.
    Clarke C; Moore A
    Clin Evid; 2002 Dec; (8):1370-85. PubMed ID: 12603943
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy in Parkinson's disease].
    Jansen EN
    Ned Tijdschr Geneeskd; 1999 Apr; 143(15):817. PubMed ID: 10347646
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical hazards of the internet: gambling in Parkinson's disease.
    Larner AJ
    Mov Disord; 2006 Oct; 21(10):1789. PubMed ID: 16941457
    [No Abstract]   [Full Text] [Related]  

  • 14. DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S74-8. PubMed ID: 12211144
    [No Abstract]   [Full Text] [Related]  

  • 15. Future therapies for Parkinson's disease.
    Hauser RA; Lyons KE
    Neurol Clin; 2004 Oct; 22(3 Suppl):S149-66. PubMed ID: 15501363
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis.
    Baker WL; Silver D; White CM; Kluger J; Aberle J; Patel AA; Coleman CI
    Parkinsonism Relat Disord; 2009 May; 15(4):287-94. PubMed ID: 18774743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DA agonists -- non-ergot derivatives: apomorphine: management of Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S83-9. PubMed ID: 12211146
    [No Abstract]   [Full Text] [Related]  

  • 18. The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?
    Mercuri NB; Bernardi G
    Trends Pharmacol Sci; 2005 Jul; 26(7):341-4. PubMed ID: 15936832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motor complications of Parkinson's disease.
    Martignoni E; Riboldazzi G; Calandrella D; Riva N
    Neurol Sci; 2003 May; 24 Suppl 1():S27-9. PubMed ID: 12774208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medicinal treatment of idiopathic Parkinson's disease].
    Klockgether T
    Nervenarzt; 2003 Mar; 74 Suppl 1():S12-21. PubMed ID: 12624679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.